Envestnet Asset Management Inc. Sells 60,335 Shares of Agilent Technologies, Inc. (NYSE:A)

Envestnet Asset Management Inc. trimmed its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 8.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 615,940 shares of the medical research company's stock after selling 60,335 shares during the period. Envestnet Asset Management Inc. owned about 0.22% of Agilent Technologies worth $72,053,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in A. Norges Bank purchased a new stake in shares of Agilent Technologies in the fourth quarter valued at about $456,963,000. GAMMA Investing LLC raised its position in Agilent Technologies by 15,648.1% in the first quarter. GAMMA Investing LLC now owns 627,247 shares of the medical research company's stock worth $73,375,000 after acquiring an additional 623,264 shares during the period. Two Sigma Investments LP raised its position in Agilent Technologies by 345.9% in the fourth quarter. Two Sigma Investments LP now owns 769,897 shares of the medical research company's stock worth $103,428,000 after acquiring an additional 597,249 shares during the period. Iron Triangle Partners LP bought a new stake in Agilent Technologies in the fourth quarter worth about $80,110,000. Finally, Marshall Wace LLP raised its position in Agilent Technologies by 280.3% in the fourth quarter. Marshall Wace LLP now owns 806,895 shares of the medical research company's stock worth $108,398,000 after acquiring an additional 594,744 shares during the period.

Analyst Ratings Changes

Several brokerages have commented on A. Barclays lifted their price objective on shares of Agilent Technologies from $115.00 to $125.00 and gave the stock an "equal weight" rating in a research report on Tuesday, June 24th. Evercore ISI lifted their target price on shares of Agilent Technologies from $125.00 to $130.00 and gave the stock an "in-line" rating in a research note on Tuesday. Jefferies Financial Group lowered their price target on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. TD Cowen boosted their price target on shares of Agilent Technologies to $150.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. Finally, UBS Group lowered their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research report on Thursday, May 29th. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $139.77.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $123.35 on Friday. The stock has a market cap of $35.04 billion, a PE ratio of 30.46, a PEG ratio of 3.77 and a beta of 1.23. The company's fifty day moving average is $115.23 and its 200 day moving average is $122.85. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. During the same period in the prior year, the business posted $1.22 EPS. The firm's revenue was up 6.0% compared to the same quarter last year. Research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be issued a $0.248 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 annualized dividend and a yield of 0.80%. Agilent Technologies's dividend payout ratio (DPR) is presently 24.44%.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.